NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, a UK-based orthobiologics company ... release of osteoinductive recombinant human bone morphogenetic protein 2 (rhBMP-2). This extended release ...

All these factors could make this a safer, simpler, and more effective bone graft for spinal fusion." Through the Breakthrough Devices program, the Amphix Bio team will have more frequent and ...

The Mayo Clinic's Lichun Lu is developing an expandable, biodegradable graft that could someday help metastatic spinal tumor patients recover from bone removal surgery. To replace the removed bone ...

The FDA expanded its clearance of Baxter International’s Altapore bioactive bone graft substitute to include its use as a supplement to autografts of a patient’s bone in posterolateral spinal ...

Wright Medical Group received federal approval for Augment, an alternative bone graft product, marking a milestone for the biotech industry after an arduous approval process. Augment is a ...

Cognitoss, a resorbable bone graft in development by Locate Bio Ltd., received U.S. FDA breakthrough device designation for treating chronic osteomyelitis, a progressive, inflammatory bone infection.

CHARLESTON, S.C.--(BUSINESS WIRE)--Paradigm BioDevices, Inc. announces the launch of VisiCORE, a new bone graft harvesting system for foot and ankle fusion surgeries designed with a clear ...

Metal implants does not bond well with natural bone and can cause complications over time. Both methods at time require more than one surgery. The alternative technology of 3D bio-printing which ...